English

1-Benzyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione

October 10, 2026

1、 Overview

1-Benzyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione (CAS 72846-00-5), a barbiturate pyrimidine heterocyclic compound, serves as an intermediate for pharmaceutical synthesis.

 

2、 Basic Product Information

Product Name: 1-Phenylmethyl-5-phenyl-barbituric acid
Synonym:1-PHENYLMETHYL-5-PHENYL-BARBITURICACID;
SODIUM1-BENZYL-5-PHENYLBARBITURICACID;
1-BENZYL-5-PHENYLBARBITURICACID;
BENZYL-5-PHENYLBARBITURICACID;
6(1h,3h,5h)-pyrimidinetrione,5-phenyl-1-(phenylmethyl)-4;
CAS NO.:.: 72846-00-5
Molecular Formula: C₁₇H₁₄N₂O₃
Molecular Weight: 294.3
Structural Formula:
Appearance: White to off-white crystalline powder
Specifications: Purity ≥98%
Related Categories: Pharmaceutical intermediates
Transport Information: Non-dangerous goods
HS Code: 2933540000
Product Manager Email: sophia@coreychem.com

 

1-Benzyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione(CAS: 72846-00-5) —  Q&A

1)

Question 1: What is the typical purity specification for commercial supply?

Answer: The commercial product is typically supplied with HPLC purity ≥98%. Grades ranging from 97% to 99% are available depending on supplier and custom requirements. Specifications also include water content, loss on drying, related impurities and other indicators, which can be customized per customer requests.

2)

Question 2: What are the main impurities likely present in this product?

Answer: Main related impurities generally include incompletely substituted barbituric acid precursors such as 5-phenylbarbituric acid and barbituric acid core, by-products generated from site-selective substitution, as well as trace residual starting materials from the synthetic route. Residual solvents are controlled in accordance with ICH guidelines. Notably, this compound is also used as an impurity reference standard for barbituric acid-related products (Barbituric Acid Impurity 4).

3)

Question 3: What are the commonly used qualitative and quantitative analytical methods?

Answer: HPLC is the primary quantitative method for purity determination, with typical detection wavelengths of 215 nm or 220 nm. Identity confirmation can be achieved by ¹H NMR, melting point measurement (163–165°C) and LC-MS. COA documents from qualified suppliers usually include HPLC, ¹H NMR and MS spectra. Vancomycin stationary phase chiral columns can be applied if chiral purity evaluation is required.

4)

Question 4: Is this compound hygroscopic?

Answer: No explicit published data confirms strong hygroscopicity for this substance. Judging from its hydrophobic property (LogP approx. 2.2–2.3), it is expected to have low hygroscopicity. Nevertheless, sealed, cool and dry storage is still recommended to prevent powder property changes or purity variation upon long-term exposure to high humidity.

5)

Question 5: What is the solubility of this compound in common solvents?

Answer: Practically insoluble to slightly soluble in water. It is soluble in acetone, moderately soluble in polar organic solvents including DMF, DMSO, dichloromethane and chloroform, while showing low solubility in aliphatic hydrocarbons.

 

4.Application Q&A 
1)

Question 1: What target compounds can be synthesized using 1-Benzyl-5-phenylbarbituric acid?
Answer: A series of N1-substituted, C5-phenyl substituted pyrimidine trione derivatives can be synthesized. Such target compounds are mainly candidate molecules for the research and development of central nervous system drugs (such as anticonvulsants and sedatives). The barbituric acid parent scaffold has been explored in the literature for various pharmacological research directions, but the most direct application of this intermediate remains focused on the development of candidate molecules related to the central nervous system. This intermediate itself is not a finished active pharmaceutical ingredient.

2)

Question 2: What advantages does this intermediate have in the synthesis of barbituric acid analogues for early drug discovery?
Answer: The pyrimidine trione core is pre-functionalized with N1-benzyl and C5-phenyl groups. This compound serves as a good starting material for SAR studies to investigate the effects of N1 substitution on receptor binding and metabolic stability. Researchers can perform derivatization at the N3-H site and examine the fundamental contributions of the fixed N1/C5 substituents to biological activity. Its predicted pKa value is 4.29 and calculated LogP is approximately 2.55. These physicochemical parameters fall within a suitable window for SAR research, accelerating the screening of active molecules in early-stage drug discovery.

3)

Question 3: What key considerations should be taken when using this intermediate for medicinal chemistry structure-activity relationship (SAR) studies?
Answer: The benzyl and phenyl substituents fixed at the N1 and C5 positions determine the basic lipophilicity and target binding interactions of the molecule. This scaffold is suitable for systematically investigating the fundamental contributions of N1-benzyl and C5-phenyl groups to receptor binding, metabolic stability and lipophilicity. Further analogue diversity can be expanded via modification at the N3 position. It should be noted that structural modifications may alter molecular target selectivity and safety profiles.

4)

Question 4: Can this intermediate be used for non-pharmaceutical research?
Answer: Its primary application is medicinal chemistry research. In non-pharmaceutical fields, there are lab-scale explorations in materials science: this compound can be used to synthesize vinyl polymers bearing its side groups for investigating the thermal and mechanical properties of materials. In dental materials, its sodium salt (Na-BzPB) is described in patents as a component of dental redox initiation systems; the free acid itself mainly acts as the precursor for preparing this salt. Barbituric acid and its derivatives are regulated prohibited substances in cosmetics, with no legal cosmetic applications. There is no large-scale industrial application outside pharmaceutical R&D.

5)

Question 5: What are the applications of this compound in pharmaceutical analysis and quality control?
Answer: 1-Benzyl-5-phenylbarbituric acid is mainly used as an impurity reference standard and reference material for chromatographic method development in pharmaceutical analysis. Commercially, it is supplied under the name “Barbituric Acid Impurity 4”, typically with a purity specification ≥98%. COA, ¹H-NMR, HPLC and MS spectra can be provided for qualitative and quantitative impurity analysis in drug filings. In addition, this compound exhibits unique retention time and spectral characteristics, and can be used as a reference standard during HPLC/LC-MS method development to optimize chromatographic separation conditions and validate detection methods for barbiturate compounds.

 

 

5.Packaging, Storage and Transportation Requirements

Packaging

Pack 1-Benzyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione in sealed chemical-grade containers. The packaging shall be dust-proof and well-sealed to prevent moisture absorption and contamination of the solid powder.

Storage

Store in a cool, dry and dark place. Keep containers tightly closed to avoid exposure to moisture and airborne impurities. Keep away from high temperature, heat sources, strong acids, strong bases and oxidizing substances. Do not store together with strong oxidants.

Transportation

Protect the packages from direct sunlight, rain and high humidity during transportation. Handle with care to prevent package breakage and powder leakage. Keep away from strong oxidants. It is not classified as dangerous goods for common transportation. In case of spillage, collect the solid dust carefully to avoid dust dispersion and avoid discharging residues into water bodies or sewers.

Shelf Life

24 months under the specified storage conditions.

 

 

6、 Product Manager Information

Contact information:

Contact: Sophia Li

Email: sophia@coreychem.com

 
Get a quote
You can also fill out our online message form and we will contact you within 24 hours.